EN DE

LifeVantage Corporation (LFVN) Fair Value & Analysis

Consumer Defensive · US · Market cap $80.9M

LC LifeVantage Corporation logo LifeVantage Corporation LFVN · US
Price$6.76
Fair Value$16.32
Upside+141.4%
Quality75/100
Watch LifeVantage Corporation for free, get notified when fair value or trend changes. Watch for free
Weak Growth
Thin margins · 3.0% net margin
Low debt · generates free cash flow
2.97% dividend yield
Ranks above peers (9/15)
Narrow moat 43/100
Evidence: High Range $12.24 – $37.67 Share as image

Fair value as of: Jul 24, 2026

From 26 valuation models · updated 17 days ago

Share price +8.3% over the past month.

A strong business, screening 141% undervalued on our models.

What matters now

  • The rarer combination: high quality (75/100) AND below fair value. That earns a closer look rather than a quick verdict.
  • The price is below even our cautious bear case ($12.24). The market is more pessimistic than our downside scenario.
  • The model range is unusually wide ($12.24 to $37.67). The outcome hinges heavily on assumptions, so read the point estimate with caution.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

$24.81 $2.69 Fair Value $16.32 Apr 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 24, 2026.

How to read this chart

60‑month range $2.69 – $24.81 · fair‑value band $12.24 – $37.67 · the $6.76 price screens below the $16.32 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 24, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

LifeVantage Corporation (LFVN) currently trades at $6.76, while our model-based Fair Value estimate is $16.32, implying the stock looks roughly 141.4% undervalued today. The Quality Score stands at 75/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.

Over the trailing twelve months, LifeVantage Corporation generated revenue of $195M at a net margin of 3.0%. Revenue declined 25.2% year over year. It earns a return on equity of 17.1%. The balance sheet holds a net cash position of $8.5M. Fundamentals as of Jul 24, 2026

Our scenario range runs from $12.24 (bear case) to $37.67 (bull case); at $6.76, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 54% below its 52-week high and 76% above its 52-week low, currently above its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -3% fair-value upside, at 141%, LFVN screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF $10.58 $16.26 $25.14 80
Residual Income $4.18 $5.90 $32.04 76
Rev-Margin DCF $11.91 $20.08 $37.17 74
All 26 models by family
DCF Models
FCF DCF $11.20 $15.17 $26.74 38
Owner Earnings $11.55 $21.41 $38.61 31
5Y Revenue Exit $10.93 $17.73 $31.96 39
5Y EBITDA Exit $12.50 $20.91 $37.39 41
5Y P/E Exit $12.74 $26.37 $44.85 38
10Y Revenue Exit $10.71 $21.02 $27.38 36
10Y EBITDA Exit $11.98 $23.91 $44.41 37
10Y P/E Exit $12.13 $24.36 $44.20 35
Earnings-Based
Graham-Dodd $5.28 $36.86 $51.72 54
Lynch FV $19.04 $27.20 $35.36 50
PEG = 1.0 $19.04 $27.20 $35.36 46
EPV $6.86 $7.52 $8.06 59
Dividend Discount
Gordon GGM $1.14 $1.91 $2.48 70
DDM Multi-Stage $1.14 $1.81 $2.06 61
Multiples
P/E Multiple $12.24 $16.32 $20.40 63
P/S Multiple $9.91 $13.21 $16.52 58
P/B Multiple $9.91 $13.21 $16.52 55
EV/EBIT $13.66 $17.77 $21.88 53
EV/EBITDA $13.20 $17.15 $21.11 54
EV/Revenue $10.13 $13.90 $17.67 43
Asset-Based
NCAV (Graham) $1.37 $1.84 $2.75 50
Growth DCF
Growth DCF $10.58 $16.26 $25.14 80
Rev-Margin DCF $11.91 $20.08 $37.17 74
Economic Profit
Residual Income $4.18 $5.90 $32.04 76
ROIC Compounder $7.91 $10.09 $12.53 72
Growth Earnings
Growth-Adj P/E $24.91 $35.58 $46.25 68

Widest divergence: Growth Earnings ($35.58) versus Dividend Discount ($1.81). Highest evidence: Growth DCF (80).

Notify me when LFVN reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) $195M
Revenue growth (YoY) -25.2%
Net margin 3.0%
Return on equity 17.1%
Free cash flow $10.5M FY2025
P/E ratio 14.2
More key figures
Operating margin 4.1%
EPS (TTM) $0.4500
Dividend yield 3.0%
EPS growth (YoY) -58.5%
Net cash $8.5M FY2025

Figures from reported company fundamentals · as of Jul 24, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 75/100

Of which business quality 75 · Market factors (momentum, volatility) 39

Profitability 80
Margins and returns on capital today
Quality Growth 61
Are margins and returns improving?
Cashflow 49
Earnings quality: real cash, not paper profit
Fin. Strength 91
Balance sheet, leverage, solvency risk
Investment 94
Disciplined investing over empire-building
Low Volatility 41
Calm price path (market factor)
Momentum 52
Price trend over the last 3–12 months (market factor)
52W Momentum 14
Distance to the 52-week high (market factor)
Net Issuance 83
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, pre and pro-biotics and skin and hair care products internationally.

Full company description

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, pre and pro-biotics and skin and hair care products internationally. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; LifeVantage Daily Wellness, a dietary supplement to strengthen immune health; LifeVantage Rise AM and Reset PM System that provides the body with the right nutrients; LifeVantage D3+, a dietary supplement that provides vitamin D3 and K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health; PhysIQ Fat Burn to support weight management; PhysIQ Prebiotic is a dietary supplement designed to support the good bacteria in the gut and a healthy microbiome; MindBody GLP-1 System, a dietary supplement that combines two products, MB Core and MB Enhance, which are designed to support weight management and wellness by activating GLP-1 naturally and balancing signals along the gut-brain axis; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. It also provides anti-aging skin care products, such as liquid collagen, facial cleansers, eye cream, moisturizing cream, sunscreen, perfecting lotions, and hand creams, as well as shampoos, nourishing conditioners, and scalp serums under the TrueScience brand name. It sells its products through its website and network of independent consultants. LifeVantage Corporation is based in Lehi, Utah.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

LifeVantage Corporation reported revenue of $229M in FY2025 versus $220M in FY2021, a compound +0.9%/yr. Reported net income was $9.8M in FY2025, compounding −6.6%/yr from FY2021.

Growth Quality 40/100
Revenue growth is weak, negative or inconsistent.
Latest Revenue (FY 2025)
$229M
Latest YoY
+14.2%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+3.5%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−0.4%
Avg. growth/yr (25Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+116.0%
Revenue +0.9%/yr
FY21 $220M
FY22 $206M
FY23 $213M
FY24 $200M
FY25 $229M
Net income −6.6%/yr
FY21 $12.9M
FY22 $3.1M
FY23 $2.5M
FY24 $2.9M
FY25 $9.8M
Character of growth · EPS growth decomposed (2014-2025) −3.5 % p.a.
Revenue per share +2.2 pp

of which total revenue +0.6 pp · buybacks/dilution +1.7 pp

EBIT margin −9.1 pp
Tax rate +1.0 pp
Residual (interest, one-offs) +2.4 pp

Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).

Watch LFVN: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "LifeVantage Corporation Fair Value". https://www.fairvalue-calculator.com/stock/LFVN

Peer Group

Packaged Foods · 649 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 75 · Top 25%
Fair Value upside +141% · Top 25%
Return on equity (TTM) 17% · Top 25%
Return on assets 6% · Top 25%
Net margin (TTM) 3% · Below median
Operating margin (TTM) 4% · Below median
Revenue growth -25% · Bottom 25%
Dividend yield (TTM) 3.0% · Above median
Debt / equity 0.10× · Higher than median

Valuation Multiples vs Packaged Foods median · lower = cheaper

P/E (TTM) 14.2× · Cheaper than median
P/B 2.33× · Pricier than median
P/S (TTM) 0.41× · Cheaper than median
P/FCF 7.7× · Pricier than median
EV/EBITDA 6.4× · Cheaper than median
PEG 0.36× · Cheaper than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 100 · sector 28
FUTURE 0 · sector 20
PAST 68 · sector 27
HEALTH 95 · sector 96
DIVIDEND 59 · sector 47

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Packaged Foods stocks, each showing price versus our Fair Value estimate (as of Jul 24, 2026).

Stock Price Fair Value vs Fair Value
Nestlé India Limited NESTLEIND ₹1,427 ₹362.37 -75%
Britannia Industries Limited BRITANNIA ₹5,413 ₹1,870 -65%
Tata Consumer Products Limited TATACONSUM ₹1,089 ₹327.27 -70%
PT Indofood CBP Sukses Makmur Tbk ICBP 6,650 IDR 15,757 IDR +137%
Samyang Foods Co 003230 1,139,000 KRW 1,010,543 KRW -11%
Patanjali Foods Limited PATANJALI ₹413.80 ₹157.04 -62%
Vietnam Dairy Products Joint Stock Company VNM 58,500 VND 68,259 VND +17%
PT Mayora Indah Tbk, MYOR 1,750 IDR 2,699 IDR +54%
PT Cisarua Mountain Dairy Tbk CMRY 4,490 IDR 4,355 IDR -3%
Nongshim Co 004370 348,500 KRW 530,619 KRW +52%

Compare LifeVantage Corporation with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is LifeVantage Corporation (LFVN) overvalued or undervalued?
As of Jul 24, 2026, our model estimates a fair value of $16.32 versus a price of $6.76, about +141% (undervalued).
What is the fair value of LFVN?
Our model-based fair value for LifeVantage Corporation is $16.32 (as of Jul 24, 2026), built from audited fundamentals. The current price is $6.76.
What is the quality score of LFVN?
LifeVantage Corporation has a Quality Score of 75/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of LifeVantage Corporation (LFVN)?
LifeVantage Corporation reported trailing-twelve-month revenue of about $195M (latest available figure, as of Jul 24, 2026).
What is the net profit margin of LFVN?
The net profit margin of LifeVantage Corporation is about 3.0%, meaning it keeps roughly 3.0% of revenue as net income. Based on the latest reported figures.
Does LifeVantage Corporation pay a dividend?
LifeVantage Corporation currently shows a dividend yield of about 2.97% relative to its recent price (as of Jul 24, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track LifeVantage Corporation and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.